Literature DB >> 33931484

Itk Promotes the Integration of TCR and CD28 Costimulation through Its Direct Substrates SLP-76 and Gads.

Enas Hallumi1, Rose Shalah1, Wan-Lin Lo2, Jasmin Corso3, Ilana Oz1, Dvora Beach1, Samuel Wittman1, Amy Isenberg1, Meirav Sela1, Henning Urlaub3,4, Arthur Weiss2,5, Deborah Yablonski6.   

Abstract

The costimulatory receptor CD28 synergizes with the TCR to promote IL-2 production, cell survival, and proliferation; yet the obligatory interdependence of TCR and CD28 signaling is not well understood. Upon TCR stimulation, Gads, a Grb2-family adaptor, bridges the interaction of two additional adaptors, LAT and SLP-76, to form a TCR-induced effector signaling complex. SLP-76 binds the Tec-family tyrosine kinase, Itk, which phosphorylates SLP-76 Y173 and PLC-γ1 Y783. In this study, we identified TCR-inducible, Itk-mediated phosphorylation of Gads Y45 in a human T cell line and in mouse primary T cells. Y45 is found within the N-terminal SH3 domain of Gads, an evolutionarily conserved domain with no known signaling function. Gads Y45 phosphorylation depended on the interaction of Gads with SLP-76 and on the dimerization-dependent binding of Gads to phospho-LAT. We provide evidence that Itk acts through SLP-76 and Gads to promote the TCR/CD28-induced activation of the RE/AP transcriptional element from the IL-2 promoter. Two Itk-related features of SLP-76, Y173 and a proline-rich Itk SH3 binding motif on SLP-76, were dispensable for activation of NFAT but selectively required for the TCR/CD28-induced increase in cytoplasmic and nuclear c-Rel and consequent RE/AP activation. We provide evidence that unphosphorylated, monomeric Gads mediates an RE/AP-directed inhibitory activity that is mitigated upon Gads dimerization and Y45 phosphorylation. This study illuminates a new, to our knowledge, regulatory module, in which TCR-induced, Itk-mediated phosphorylation sites on SLP-76 and Gads control the transcriptional response to TCR/CD28 costimulation, thus enforcing the obligatory interdependence of the TCR and CD28 signaling pathways.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33931484      PMCID: PMC8113088          DOI: 10.4049/jimmunol.2001053

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  97 in total

1.  Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line.

Authors:  B J Irvin; B L Williams; A E Nilson; H O Maynor; R T Abraham
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9.

Authors:  Philipp S van de Weyer; Michael Muehlfeit; Christoph Klose; Joseph V Bonventre; Gerd Walz; E Wolfgang Kuehn
Journal:  Biochem Biophys Res Commun       Date:  2006-10-23       Impact factor: 3.575

3.  DEF6, a novel substrate for the Tec kinase ITK, contains a glutamine-rich aggregation-prone region and forms cytoplasmic granules that co-localize with P-bodies.

Authors:  Fiona Hey; Nathan Czyzewicz; Peter Jones; Fred Sablitzky
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

4.  A specific intermolecular association between the regulatory domains of a Tec family kinase.

Authors:  K N Brazin; D B Fulton; A H Andreotti
Journal:  J Mol Biol       Date:  2000-09-22       Impact factor: 5.469

5.  Sequential Steps of CRAC Channel Activation.

Authors:  Raz Palty; Zhu Fu; Ehud Y Isacoff
Journal:  Cell Rep       Date:  2017-05-30       Impact factor: 9.423

Review 6.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

7.  Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.

Authors:  W S Pear; J P Miller; L Xu; J C Pui; B Soffer; R C Quackenbush; A M Pendergast; R Bronson; J C Aster; M L Scott; D Baltimore
Journal:  Blood       Date:  1998-11-15       Impact factor: 22.113

8.  Quantitative analysis of phosphotyrosine signaling networks triggered by CD3 and CD28 costimulation in Jurkat cells.

Authors:  Ji-Eun Kim; Forest M White
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

9.  Release of serine/threonine-phosphorylated adaptors from signaling microclusters down-regulates T cell activation.

Authors:  Rémi Lasserre; Céline Cuche; Ronnie Blecher-Gonen; Evgeny Libman; Elise Biquand; Anne Danckaert; Deborah Yablonski; Andrés Alcover; Vincenzo Di Bartolo
Journal:  J Cell Biol       Date:  2011-11-21       Impact factor: 10.539

10.  Phosphoproteomic Analyses of Interleukin 2 Signaling Reveal Integrated JAK Kinase-Dependent and -Independent Networks in CD8(+) T Cells.

Authors:  Sarah H Ross; Christina Rollings; Karen E Anderson; Phillip T Hawkins; Len R Stephens; Doreen A Cantrell
Journal:  Immunity       Date:  2016-08-23       Impact factor: 31.745

View more
  3 in total

1.  SILAC Phosphoproteomics Reveals Unique Signaling Circuits in CAR-T Cells and the Inhibition of B Cell-Activating Phosphorylation in Target Cells.

Authors:  Alijah A Griffith; Kenneth P Callahan; Nathan Gordo King; Qian Xiao; Xiaolei Su; Arthur R Salomon
Journal:  J Proteome Res       Date:  2022-01-11       Impact factor: 4.466

2.  Robust T cell activation requires an eIF3-driven burst in T cell receptor translation.

Authors:  Dasmanthie De Silva; Lucas Ferguson; Grant H Chin; Benjamin E Smith; Ryan A Apathy; Theodore L Roth; Franziska Blaeschke; Marek Kudla; Alexander Marson; Nicholas T Ingolia; Jamie Hd Cate
Journal:  Elife       Date:  2021-12-31       Impact factor: 8.140

Review 3.  ZAP70, too little, too much can lead to autoimmunity.

Authors:  Judith F Ashouri; Wan-Lin Lo; Trang T T Nguyen; Lin Shen; Arthur Weiss
Journal:  Immunol Rev       Date:  2021-12-18       Impact factor: 10.983

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.